Topical treatment of nasal keratoacanthoma [17]

Plastic and Reconstructive Surgery

Volumn 117, Issue 7, 2006, Pages 2516-2517

  Denkler, Keith ^a,b   Kivett, William F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADULT; CANCER SURGERY; CASE REPORT; DISEASE COURSE; FEMALE; FOREHEAD FLAP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; LETTER; NOSE TUMOR; PRIORITY JOURNAL; ARTICLE; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; KERATOACANTHOMA; MIDDLE AGED; NOSE NEOPLASMS; TREATMENT OUTCOME;

EID: 33745331068     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000220002.89661.b4     Document Type: Letter

References (5)

1. Dockrell, D. H., and Kinghorn, G. R. Imiquimod and resiquimod as novel immunomodulators. J. Antimicrob. Chemother. 48: 751, 2001.
2. Di Lernia, V., Ricci, C., and Albertini, G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J. Eur. Acad. Dermatol. Venereol. 18: 626, 2004.
3. Bhatia, N. Imiquimod as a possible treatment for keratoacanthoma. J. Drugs Dermatol. 3: 71, 2004.
4. Peris, K., Micantonio, T., and Fargnoli, M. C. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream. Eur. J. Dermatol. 13: 413; reply 415, 2003.
5. Dendorfer, M., Oppel, T., Wollenberg, A., and Prinz, J. C. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur. J. Dermatol. 13: 80, 2003.